The Value of a QofE Beyond Standard EBITDA Normalizations
The Value of a QofE Beyond Standard EBITDA Normalizations
| Topic | EBITDA Normalization & QofE |
| Audience | PE Sponsors, Deal Teams, CFOs, Lenders |
| Stage | Pre-LOI Through Due Diligence |
| Applies To | Middle Market M&A Transactions |
- EBITDA normalization removes non-recurring items from reported earnings, but it does not assess whether the revenue and margins that remain are sustainable or accurately presented.
- Seller-prepared normalization adjustments are frequently overstated and require independent verification before they can be relied upon in valuation or debt underwriting.
- A Quality of Earnings review goes further: it evaluates revenue quality, customer concentration, accounting policy, working capital, and the assumptions behind management's projections.
- At 7x to 10x EBITDA multiples, a $500,000 overstatement in adjusted EBITDA translates directly into $3.5 to $5 million in purchase price exposure.
Every middle market PE transaction arrives with a seller-prepared adjusted EBITDA bridge. The logic is familiar: remove the owner's personal expenses, add back a one-time legal charge, normalize for a non-recurring contract, and present the result as the business's true run-rate earnings. This process is necessary. The problem is that deal teams too often treat it as sufficient.
EBITDA normalization answers one question: what should be removed from reported earnings? It does not evaluate whether the revenue underlying those earnings is concentrated in one or two customers with expiring contracts, whether the company's revenue recognition policies are conservative or aggressive, or whether growing the business will require working capital that compresses free cash flow well below what the EBITDA multiple implies. Those questions require a Quality of Earnings review, and when sponsors skip that step, they are underwriting against a number they have not fully tested.
Where Normalization Falls Short
Seller adjustments, including excess owner compensation, one-time costs, and pro forma revenue from contracts under negotiation, are almost always presented optimistically. Independent QofE work routinely finds that a meaningful share of seller-presented add-backs are either partially supportable or unsupported when subjected to documentary review.
At an 8x purchase price multiple, a $750,000 reduction in independently supportable EBITDA represents $6 million in overpayment. That gap does not close through post-close operational improvement, as it is locked into the deal structure at signing.
Beyond the adjustments themselves, normalization leaves the most consequential risks unexamined. Revenue concentration, contract renewal risk, aggressive cost capitalization, and working capital dynamics that imply a cash-consumptive business at growth, none of these appear in a normalization bridge. They appear in a QofE review, and they routinely change how a sponsor structures a deal, prices leverage, or sizes a working capital peg.
What a QofE Review Actually Provides
A Quality of Earnings engagement independently verifies the normalization adjustments, then goes further: it disaggregates revenue by customer and contract to assess concentration and renewal risk, evaluates whether accounting policies are consistent with applicable standards, calculates a normalized working capital requirement, and tests management's projections against historical performance. The result is an independently supported EBITDA figure that a deal team, and its lenders, can underwrite against with confidence.
The cost of a QofE review is small relative to the exposure it addresses. The transactions most likely to underperform are not those in which due diligence surfaced a problem. They are the ones in which the sponsor relied on normalized EBITDA and discovered the gap only after close.
Summary
EBITDA normalization is a necessary step in PE deal analysis, but it is not a substitute for a Quality of Earnings review. Normalization removes non-recurring items; it does not assess the quality or sustainability of what remains. In middle market transactions priced at 7x to 10x EBITDA, the difference between seller-adjusted and independently supported earnings has direct and material consequences for purchase price, leverage, and post-close performance. A QofE engagement provides the independent verification and broader analytical coverage that normalization alone cannot.
The Value of a QofE Beyond Standard EBITDA Normalizations
The Value of a QofE Beyond Standard EBITDA Normalizations
Every middle market PE transaction arrives with a seller-prepared adjusted EBITDA bridge. The logic is familiar: remove the owner's personal expenses, add back a one-time legal charge, normalize for a non-recurring contract, and present the result as the business's true run-rate earnings. This process is necessary. The problem is that deal teams too often treat it as sufficient.
EBITDA normalization answers one question: what should be removed from reported earnings? It does not evaluate whether the revenue underlying those earnings is concentrated in one or two customers with expiring contracts, whether the company's revenue recognition policies are conservative or aggressive, or whether growing the business will require working capital that compresses free cash flow well below what the EBITDA multiple implies. Those questions require a Quality of Earnings review, and when sponsors skip that step, they are underwriting against a number they have not fully tested.
Where Normalization Falls Short
Seller adjustments, including excess owner compensation, one-time costs, and pro forma revenue from contracts under negotiation, are almost always presented optimistically. Independent QofE work routinely finds that a meaningful share of seller-presented add-backs are either partially supportable or unsupported when subjected to documentary review.
At an 8x purchase price multiple, a $750,000 reduction in independently supportable EBITDA represents $6 million in overpayment. That gap does not close through post-close operational improvement, as it is locked into the deal structure at signing.
Beyond the adjustments themselves, normalization leaves the most consequential risks unexamined. Revenue concentration, contract renewal risk, aggressive cost capitalization, and working capital dynamics that imply a cash-consumptive business at growth, none of these appear in a normalization bridge. They appear in a QofE review, and they routinely change how a sponsor structures a deal, prices leverage, or sizes a working capital peg.
What a QofE Review Actually Provides
A Quality of Earnings engagement independently verifies the normalization adjustments, then goes further: it disaggregates revenue by customer and contract to assess concentration and renewal risk, evaluates whether accounting policies are consistent with applicable standards, calculates a normalized working capital requirement, and tests management's projections against historical performance. The result is an independently supported EBITDA figure that a deal team, and its lenders, can underwrite against with confidence.
The cost of a QofE review is small relative to the exposure it addresses. The transactions most likely to underperform are not those in which due diligence surfaced a problem. They are the ones in which the sponsor relied on normalized EBITDA and discovered the gap only after close.
Summary
EBITDA normalization is a necessary step in PE deal analysis, but it is not a substitute for a Quality of Earnings review. Normalization removes non-recurring items; it does not assess the quality or sustainability of what remains. In middle market transactions priced at 7x to 10x EBITDA, the difference between seller-adjusted and independently supported earnings has direct and material consequences for purchase price, leverage, and post-close performance. A QofE engagement provides the independent verification and broader analytical coverage that normalization alone cannot.
RECENT NEWS
McLean advised Vanteon on announced acquisition by PDW
The McLean Group served as exclusive financial advisor to Vanteon Corporation on its announced acquisition by PDW Holdings, Inc., an American drone company that designs, engineers, and manufactures unmanned systems and solutions for defense and public safety. Based in Rochester, NY, Vanteon brings more than 40 years of advanced communications, RF, and software-defined radio expertise to PDW, strengthening the company’s ability to deliver resilient connectivity and next-generation sUAS capabilities at the tactical edge. The transaction reinforces The McLean Group’s continued leadership advising Defense and Unmanned Systems sector companies through transformative transactions. […]
Labor Retention and Quality of Earnings: Understanding People-Driven Margin Risk
Workforce stability is one of the most overlooked drivers of earnings quality and in people-driven businesses, it can make or break a transaction.Workforce stability is one of the most overlooked drivers of earnings quality and in people-driven businesses, it can make or break a transaction. In this article, The McLean Group’s Financial Consulting team examines how labor retention risk surfaces during a Quality of Earnings analysis, why below-market compensation and key-person dependencies can distort reported EBITDA, and what buyers and sellers should evaluate before reaching the diligence table. From government contracting to IT services and professional services, the people behind the numbers matter just as much as the numbers themselves, and understanding that dynamic is increasingly essential to assessing the true sustainability of earnings in any middle market transaction.[…]
How Earnouts Affect Transaction Valuation: The Technical Framework Under ASC 805
Earnouts are one of the most powerful and most misunderstood tools in middle-market M&A. When buyers and sellers cannot agree on value, a well-structured earnout bridges the gap. But under ASC 805, the accounting treatment is anything but simple: contingent consideration must be measured at fair value on Day One, classified as liability or equity with real P&L consequences, and remeasured every reporting period for the life of the arrangement. For PE sponsors and portfolio company CFOs, the decisions made at the term sheet stage, including metric selection, settlement structure, and discount rate methodology, determine not just deal economics but how results are reported to lenders, boards, and investors long after close. This article breaks down the technical framework so you can structure earnouts that work the way you intend them to. […]